Brief: Flerie Portfolio Firm Reports Positive Bladder Cancer Data
20/05/2026 10:01
May 20 (Reuters) - Flerie AB FLERIE.ST: FLERIE'S PORTFOLIO COMPANY PROKARIUM PRESENTS POSITIVE INTERIM DATA FROM CLINICAL STUDY IN BLADDER CANCER DRUG CANDIDATE'S SAFETY PROFILE IS CONSIDERED FAVOURABLE Source text: ID:nMFNc883wB Further company coverage: FLERIE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))